Using avastin (bevacizumab) for macula degeneration treatment?

Avastin (bevacizumab): Avastin (bevacizumab) is a drug that is commonly used in the treatment of wet macular degeneration and other eye conditions involving leakage of fluid from blood vessels in the retina.

See below: Avastin, lucentis, (ranibizumab) and Eylea are commonly used for the wet form of macular degeneration. Eylea is the newest and lasts the longest once injected into the eye. Ask your retina specialist if you are a candidate.

Genetic Disease: Age-related macular degeneration is a chronic disease of the central part of the retina. It is broken down into two types, the dry form , which involves slow, patchy deterioration of retinal cells, and the wet form which is caused by bleeding and leads to rapid vision loss. Current treatment for the wet type is intravitreal injections with eylea, lucentis, (ranibizumab) or avastin.